IOVA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -5.62. Updated 2026-07-23.
Iovance Biotherapeutics (IOVA) Research Hub
Iovance Biotherapeutics (IOVA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 8.6 USD (+2.02%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.62, market cap 1.85B. This hub links to the full technical, earnings and options research available for IOVA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.6 USD (+2.02%) |
| 52-week range | 3.76 USD – 9.3 USD |
| Trend regime | Range |
| 14-day RSI | 79.4 (Overbought) |
| Trailing P/E | -5.62 |
| Market cap | 1.85B |
| Dividend yield | 0.00% |
Available research for IOVA
Covered Call on IOVA: how it works, illustrative setup around the real 8.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IOVA: how it works, illustrative setup around the real 8.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IOVA: how it works, illustrative setup around the real 8.6 USD price, max profit/loss, breakeven and when to use it. Educational.
IOVA technical analysis: range, last 8.6 USD, RSI 79.4, 52w range 3.76 USD–9.3 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IOVA in?
Iovance Biotherapeutics (IOVA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IOVA in an uptrend or downtrend?
As of 2026-09-11, IOVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IOVA's trailing P/E ratio?
IOVA's trailing P/E is -5.62, with a market cap of 1.85B. See the earnings research page for full valuation detail.